Deep Bio today announced the publication of a study evaluating the performance of its AI algorithm for breast cancer analysis to accurately differentiate between invasive ductal carcinoma (IDC) lesions from non-invasive ductal carcinoma in situ (DCIS) lesions in biopsies taken after breast cancer surgery.
Seoul, Korea, March 23, 2022 (PRWEB) March 23, 2022 Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced five research studies